Effects of Glucan and Vitamin D Supplementation on Obesity and Lipid Metabolism in Diabetic Retinopathy

Background: Diabetes mellitus is a chronic disease manifested by an increase of blood glucose. Objective: To evaluate the effects of glucan and vitamin D supplementation in patients with diabetic retinopathy. Method: We evaluated the effects of 3-month supplementation with glucan and vitamin D in 54 patients with diabetic retinopathy. We measured levels of vitamin D, cholesterol, HDL cholesterol, and triglycerides. Results: The supplementation strongly decreased the cholesterol levels and improved the levels of HDL cholesterol. In addition, vitamin D levels were strongly improved, but still not at optimal values. Conclusion: From our data, we concluded that glucan and vitamin D supplementation strongly influence lipid metabolism and have positive effects on human health.

• Publication year

  2018

• Venue

  Open Biochemistry Journal

• Publication date

  2018-03-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1874091X01812010036PMID 29760812PMCID 5897984
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Food Ingredients That Inhibit Cholesterol Absorption

  2017cited by this paper
• Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency

  2017cited by this paper
• Vitamin D status is inversely associated with markers of risk for type 2 diabetes: A population based study in Victoria, Australia

  2017cited by this paper
• Body mass index and risk of diabetic retinopathy

  2017cited by this paper
• Mushroom Polysaccharides: Chemistry and Antiobesity, Antidiabetes, Anticancer, and Antibiotic Properties in Cells, Rodents, and Humans

  2016cited by this paper
• Protective role of sulphoraphane against vascular complications in diabetes

  2016cited by this paper
• Cholesterol-Lowering Effect of Beta Glucan Extracted from Saccharomyces cerevisiae in Rats

  2016cited by this paper
• Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet

  2016cited by this paper
• An Updated Mini Review of Vitamin D and Obesity: Adipogenesis and Inflammation State

  2016cited by this paper
• The Role of Systemic Risk Factors in Diabetic Retinopathy

  2016influential reference
• The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials

  2016cited by this paper
• Why so Many Glucans

  2016cited by this paper
• Glucans and Cancer: Historical Perspective

  2015cited by this paper
• A novel quantitative body shape score for detecting association between obesity and hypertension in China

  2015influential reference
• Effect of polycan, a β-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model

  2015cited by this paper
• Determinants of vitamin D status in Caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors.

  2015influential reference
• Modulation of Cholesterol-Related Gene Expression by Dietary Fiber Fractions from Edible Mushrooms.

  2015cited by this paper
• Beneficial effects of the nutritional supplements on the development of diabetic retinopathy

  2014cited by this paper
• The cholesterol-lowering effects of oat varieties based on their difference in the composition of proteins and lipids

  2014cited by this paper
• Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials1234

  2014cited by this paper
• Anti-Stress Action of an Orally-Given Combination of Resveratrol, β-Glucan, and Vitamin C

  2014cited by this paper
• Clinical trials of yeast-derived β-(1,3) glucan in children: effects on innate immunity.

  2014cited by this paper
• Role of dietary beta-glucans in the prevention of the metabolic syndrome.

  2012cited by this paper
• A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index

  2012influential reference
• Baker's Yeast Beta-Glucan Supplement Reduces Upper Respiratory Symptoms and Improves Mood State in Stressed Women

  2012cited by this paper
• Beta Glucan: Health Benefits in Obesity and Metabolic Syndrome

  2011cited by this paper
• Anti-stress action of several orally-given β-glucans.

  2010cited by this paper
• Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist–Hip Ratio

  2010cited by this paper
• Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.

  2010cited by this paper
• Effects of yeast-derived β-glucans on blood cholesterol and macrophage functionality

  2009cited by this paper
• Glucans as biological response modifiers.

  2009cited by this paper
• Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial

  2007cited by this paper
• Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease.

  2000cited by this paper
• Cholesterol-lowering effects of dietary fiber: a meta-analysis.

  1999cited by this paper
• Oat beta-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects.

  1994cited by this paper
• Hypocholesterolemic effects of oat and bean products.

  1988cited by this paper
• Hypocholesterolemic effects of oat-bran or bean intake for hypercholesterolemic men.

  1984cited by this paper

• Functional Food Intervention Attenuates Obesity‐Induced Metabolic and Intestinal Microbiota Changes in Rats

  2025cites this paper
• Effect of Oat (Avena sativa L.) Consumption on Lipid Profile with Focus on Triglycerides and High-density Lipoprotein Cholesterol (HDL-C): An Updated Systematic Review.

  2022cites this paper
• Beneficial effects of vitamin D in the management of untreated hyperlipidemia in diabetic patients in Erbil, Iraq

  2022cites this paper
• Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases

  2022cites this paper
• Vitamin D and Ocular Diseases: A Systematic Review

  2022cites this paper
• Vitamin D deficiency and cardiovascular risk in type 2 diabetes population

  2021cites this paper
• Serum Vitamin D Levels and Risk Factors for Cardiovascular Complication in Diabetes

  2021cites this paper
• Hypolipidemic Effects of β-Glucans, Mannans, and Fucoidans: Mechanism of Action and Their Prospects for Clinical Application

  2020cites this paper
• Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects

  2020cites this paper
• Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy

  2020cites this paper
• How to boost the immune defence prior to respiratory virus infections with the special focus on coronavirus infections

  2020cites this paper
• Glucans as New Anticancer Agents

  2019cites this paper
• Diabetic Retinopathy: Changes in Levels of Orosomucoids in Patients Supplemented with Beta Glucan and Vitamin D

  2018cites this paper
• Vitamin D and β-glucan supplementation affects levels of leptin, apolipoproteins and general nutrition state in patients with diabetic retinopathy

  2018cites this paper